The European Union (EU) Clinical Trials Regulation (CTR) officially
The United States’ recent escalation in tariff policies, particularly
Which new market entrants should be on the industry’s radar
The pharmaceutical sector has been a major focus for the Trump Administration,
In 2024, life sciences companies pivoted away from large-scale mergers
As 2024 nears its end, the contract development and manufacturing organization (CDMO)